Nicotinamide can block proliferation and promote apoptosis of chronic lymphocytic leukemia cells with wild-type p53 via the p53/miR-34a/SIRT1 pathway [14]. This evidence concerns the gene SIRT1 and B-cell chronic lymphocytic leukemia.